{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2(Suppl 3)"],"submitter":["Meyerhardt J"],"journal":["Journal for immunotherapy of cancer"],"pagination":["P71-P71"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4288729"],"repository":["biostudies-literature"],"pubmed_title":["A Phase III open-label, randomized, multicenter study of imprime pgg in combination with cetuximab in patients with kras wild type metastatic colorectal cancer"],"pmcid":["PMC4288729"],"pubmed_authors":["Gargano M","Grady M","Braun A","Huhn R","Meyerhardt J","Lowe J"],"additional_accession":[]},"is_claimable":false,"name":"A Phase III open-label, randomized, multicenter study of imprime pgg in combination with cetuximab in patients with kras wild type metastatic colorectal cancer","description":null,"dates":{"release":"2014-01-01T00:00:00Z","publication":"2014 Jan","modification":"2025-04-22T07:11:20.544Z","creation":"2025-04-05T22:03:27.554Z"},"accession":"S-EPMC4288729","cross_references":{}}